Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)

✍ Scribed by John J.V. McMurray; Hajime Uno; Petr Jarolim; Akshay S. Desai; Dick de Zeeuw; Kai-Uwe Eckardt; Peter Ivanovich; Andrew S. Levey; Eldrin F. Lewis; Janet B. McGill; Patrick Parfrey; Hans-Henrik Parving; Robert M. Toto; Scott D. Solomon; Marc A. Pfeffer

• Book ID: 116192576
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 463 KB
• Volume: 162
• Category: Article
• ISSN: 1097-6744
• DOI: 10.1016/j.ahj.2011.07.016